In addition to our three main focuses of cardiovascular diseases, diabetes and pain, we are also active in other therapeutic areas, with preparations for the treatment of everything from respiratory diseases to shingles, for example.
In 2012, we added a new field to our specialisms, with cancer research: In collaboration with our partner Oxford BioTherapeutics, we are developing five antibody-based drugs to treat cancer.